Filter News
Area of Research
News Topics
- (-) Composites (2)
- (-) Energy Storage (4)
- (-) Fusion (1)
- (-) Isotopes (3)
- (-) Materials Science (8)
- (-) Security (1)
- (-) Space Exploration (1)
- (-) Sustainable Energy (9)
- 3-D Printing/Advanced Manufacturing (11)
- Advanced Reactors (2)
- Artificial Intelligence (2)
- Bioenergy (8)
- Biology (1)
- Biomedical (4)
- Biotechnology (1)
- Chemical Sciences (2)
- Climate Change (3)
- Computer Science (9)
- Coronavirus (4)
- Decarbonization (1)
- Environment (6)
- Exascale Computing (1)
- High-Performance Computing (1)
- Machine Learning (2)
- Materials (2)
- Microscopy (1)
- Molten Salt (1)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (15)
- Nuclear Energy (6)
- Physics (4)
- Polymers (2)
- Quantum Science (2)
- Summit (5)
- Transformational Challenge Reactor (2)
- Transportation (4)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.